On November 26th, 2024, MORSE Consulting’s Sang Mi Lee, MBA, BSc Phm, RPh presented at the Fall 2024 Rare Disease Conference on innovative agreements that could facilitate access. Sang Mi discussed case studies to highlight various ways innovative performance-based agreements could be structured, leveraging simple claims data to more robust real-world evidence.
MORSE thanks both the Canadian Organization for Rare Disorders (CORD) and Regroupement québécois des maladies orphelines (RQMO) for hosting this successful event to connect the passionate stakeholders in this space, ensuring that important patient stories and journeys are highlighted, and empower all of us to continue to work together for improvements in timely diagnosis and treatment of rare diseases.
